STALing B cell responses with CD22

被引：3

作者：

Chappell, Craig P. ^{[1
]}

Clark, Edward A. ^{[1
]}

机构：

[1] Univ Washington, Dept Immunol, Seattle, WA 98195 USA

来源：

JOURNAL OF CLINICAL INVESTIGATION | 2013年 / 123卷 / 07期

关键词：

PLASMACYTOID DENDRITIC CELLS; ANTIGEN DELIVERY; FACTOR-VIII; T-CELL; ENHANCEMENT; SIGNALS;

D O I：

10.1172/JCI69670

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Suppressing unwanted humoral immune responses without compromising the host's ability to respond to foreign pathogens is a primary goal for therapies aimed at ameliorating harmful autoantibody production. Global suppression of the immune system via lymphocyte depletion and/or immunosuppressive drugs can have off-target effects, a limitation to conventional therapies. In this issue of the JCI, Macauley and colleagues utilize a novel platform to inhibit antigen-specific antibody production that preserves the immune system's ability to respond to unrelated antigens.

引用

页码：2778 / 2780

页数：3

共 50 条

[31] The role of B cell CD22 expression in Staphylococcus aureus arthritis and sepsis
Gjertsson, I
Nitschke, L
Tarkowski, A
MICROBES AND INFECTION, 2004, 6 (04) : 377 - 382
[32] THE B-CELL ANTIGEN CD22 MEDIATES MONOCYTE AND ERYTHROCYTE ADHESION
STAMENKOVIC, I
SEED, B
NATURE, 1990, 345 (6270) : 74 - 77
[33] IN VIVO EFFECTS OF EPRATUZUMAB, A MONOCLONAL ANTIBODY TARGETING HUMAN CD22, ON B CELL FUNCTION IN HUMAN CD22 KNOCK-IN (HUKI) MICE
Brandl, C.
Oezgoer, L.
Woehner, M.
Shock, A.
Nitschke, L.
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 811 - 811
[34] Role in B cell activation for CD22 and the protein tyrosine phosphatase SHP
Doody, G.M.
Justement, L.B.
Delibrias, C.C.
Matthews, R.J.
Lin, J.
Thomas, M.L.
Fearon, D.T.
Science, 1995, 269 (5221)
[35] In vivo targeting of B-cell lymphoma with glycan ligands of CD22
Chen, Weihsu C.
Completo, Gladys C.
Sigal, Darren S.
Crocker, Paul R.
Saven, Alan
Paulson, James C.
BLOOD, 2010, 115 (23) : 4778 - 4786
[36] In Vivo Effects of Epratuzumab, a Monoclonal Antibody Targeting Human CD22, on B Cell Function in Human CD22 Knock-in (Huki) Mice
Brandl, Carolin
Oezgoer, Lamia
Woehner, Miriam
Shock, Anthony
Nitschke, Lars
ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S855 - S856
[37] Receptor modulators of B-cell receptor signalling - CD19/CD22
Smith, KGC
Fearon, DT
SIGNAL TRANSDUCTION AND THE COORDINATION OF B LYMPHOCYTE DEVELOPMENT AND FUNCTION I: TRANSDUCTION OF BCR SIGNALS FROM THE CELL MEMBRANE TO THE NUCLEUS, 2000, 245 : 195 - 212
[38] CD22 Regulates TLR Signaling in B Cells
Kawasaki, Norihito
Paulson, James
GLYCOBIOLOGY, 2009, 19 (11) : 1289 - 1290
[39] CD19 regulates CD22 function in B cell development and B cell antigen receptor signal transduction
Bradney, AP
Fujimoto, M
Poe, JC
Tedder, TF
FASEB JOURNAL, 1999, 13 (05): : A987 - A987
[40] Signal transduction via the human B lymphocyte antigen CD22 results in a potent B cell stimulatory signal and the association of CD22 with a complex of effector molecules.
Tuscano, JM
Kehrl, JH
JOURNAL OF INVESTIGATIVE MEDICINE, 1996, 44 (03) : A241 - A241

← 1 2 3 4 5 →